Ligand Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:LGND Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
23 Mar 26	SellUS$207,873	Stephen Sabba	Individual	1,000	US$207.87
12 Dec 25	SellUS$339,711	Octavio Espinoza	Individual	1,804	US$188.31
23 Sep 25	SellUS$1,708,088	Jason Aryeh	Individual	10,000	US$171.92
23 Jun 25	SellUS$57,042	Andrew Reardon	Individual	500	US$114.08
10 Jun 25	SellUS$57,271	Andrew Reardon	Individual	500	US$114.54

Insider Trading Volume

Insider Buying: LGND insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of LGND?
Owner Type	Number of Shares	Ownership Percentage
State or Government	4,379	0.02%
Individual Insiders	468,557	2.15%
Institutions	21,370,474	97.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 73.84% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
14.8%	BlackRock, Inc.	2,961,886	US$687.0m	0.74%	0.01%
5.49%	Vanguard Portfolio Management, LLC	1,100,267	US$255.2m	0%	0.01%
5.04%	Janus Henderson Group plc	1,009,891	US$234.3m	1.46%	0.08%
4.23%	Vanguard Capital Management, LLC	848,089	US$196.7m	0%	no data
3.89%	State Street Global Advisors, Inc.	778,856	US$180.7m	3.68%	0.01%
2.97%	FMR LLC	594,483	US$137.9m	2.93%	0.01%
2.86%	Nomura Investment Management Business Trust	573,312	US$133.0m	-11%	0.17%
2.86%	Franklin Resources, Inc.	572,740	US$132.9m	15.5%	0.04%
2.8%	Chicago Capital, LLC	561,675	US$130.3m	0.04%	3.12%
2.79%	Geode Capital Management, LLC	558,934	US$129.7m	13.2%	0.01%
2.79%	Invesco Ltd.	558,364	US$129.5m	71.2%	0.03%
2.52%	Congress Asset Management Company, LLP	504,637	US$117.1m	5.12%	0.75%
2.47%	Stephens Investment Management Group, LLC	494,670	US$114.7m	-1.27%	1.38%
2.12%	Dimensional Fund Advisors LP	425,230	US$98.6m	-1.79%	0.01%
2.05%	Massachusetts Financial Services Company	411,543	US$95.5m	-18.8%	0.02%
1.76%	Loomis Sayles & Company, L.P.	353,209	US$81.9m	-7.7%	0.1%
1.58%	UBS Asset Management AG	317,468	US$73.6m	-37.3%	no data
1.53%	Deutsche Asset & Wealth Management	305,865	US$70.9m	-0.58%	0.02%
1.51%	Victory Capital Management Inc.	303,224	US$70.3m	18.3%	0.04%
1.43%	DWS Investment Management Americas, Inc.	286,460	US$66.4m	-0.01%	0.26%
1.41%	Rice Hall James & Associates, LLC	283,567	US$65.8m	1.41%	3.5%
1.34%	Ranger Investment Management, L.P.	267,943	US$62.2m	-0.76%	3.99%
1.32%	Invesco Capital Management LLC	265,240	US$61.5m	39.4%	0.01%
1.27%	Northern Trust Global Investments	254,158	US$59.0m	1.4%	0.01%
1.04%	Ashford Capital Management Inc	207,565	US$48.1m	-2.91%	5.3%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/05/31 08:19
End of Day Share Price	2026/05/29 00:00
Earnings	2026/03/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Ligand Pharmaceuticals Incorporated is covered by 20 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Jasper Hellweg	Argus Research Company
Robert Wasserman	Benchmark Company
Jason Zemansky	BofA Global Research